Research final exam PHA 309

Description

1 Pharmacy Quiz on Research final exam PHA 309, created by TUAN TRAN on 07/10/2017.
TUAN TRAN
Quiz by TUAN TRAN, updated more than 1 year ago
TUAN TRAN
Created by TUAN TRAN over 6 years ago
7
1

Resource summary

Question 1

Question
Which of the following are Primary Literature are primary literatures:
Answer
  • Clinical trial
  • Pharmaceutical research
  • Educational assessment
  • Drug references (micromedex,Lexicomp)
  • Review articles
  • Clinical practice guidelines
  • Cohort studies

Question 2

Question
Pubmed is a tertiary source.
Answer
  • True
  • False

Question 3

Question
Case series and case reports are
Answer
  • Primary
  • Tertiary
  • Secondary

Question 4

Question
Which of the followings belong to Experimental studies.
Answer
  • Cohort
  • Educational assesment
  • Clinical trial
  • Cross-sectional
  • Case control
  • Pharmaceutical research

Question 5

Question
Observational studies includes
Answer
  • Clinical trial
  • Pharmaceutical research
  • Case control
  • Cohort
  • Cross-sectional

Question 6

Question
Prescription drug spending is one of its fastest growing components, increasing at double-digit rates in Health care spending each of the past 7 years.
Answer
  • True
  • False

Question 7

Question
There are several components to this rapid rise in spending of Prescription drugs:
Answer
  • more prescriptions are being written
  • prices of existing drugs are rising
  • higher-priced new drugs are replacing existing drugs
  • More drug manufactures are on the market.
  • More Pharmacist students graduated.

Question 8

Question
IN pre-clinical trial, ____________ is preferred.
Answer
  • Intent to treat
  • Per-protocol

Question 9

Question
In clinical trial phase, in order to measure safety and effectiveness, _____________ is preferred.
Answer
  • Intent to treat
  • Per protocol

Question 10

Question
Literature review should be accurate and balanced in Introduction.
Answer
  • True
  • False

Question 11

Question
In __________, missing data is filled with the last data
Answer
  • Extreme case analysis.
  • LOCF.
  • Complete case analysis.

Question 12

Question
In ______________, patient in the drug group is being given the worst data while patient in placebo group is being given
Answer
  • Complete case analysis
  • Extreme case analysis
  • LOCF

Question 13

Question
In __________, if data is missing, patient in drug group will be given the best data.
Answer
  • Extreme case analysis
  • Complete case analysis
  • LOCF

Question 14

Question
Randomization will limit selection bias.
Answer
  • True
  • False

Question 15

Question
Three things to look for regarding to safety.
Answer
  • Adverse effects
  • Common effects
  • Number of people drop out due to adverse drug events
  • Number of patient attend the trial

Question 16

Question
DCTA is promotional advertising of pharmaceutical products directly to consumers vias:
Answer
  • Facebook
  • Magazine & newspapers ads
  • product placement
  • Web sites & other internet sites.
  • Referral program.
  • Trials.

Question 17

Question
DCTA is defined as good education for patients that doesn't influence providers' prescribing practices.
Answer
  • True
  • False

Question 18

Question
Pharmaceutical manufacturers use several types of promotions. They are
Answer
  • Detailings (29% of spending)
  • Sampling (55% of spending)
  • Direct to consumer (DTC) advertising (14% of spending)
  • None of these above.

Question 19

Question
The drugs most heavily promoted to both consumers and physicians are typical drugs that treat acute conditions.
Answer
  • True
  • False

Question 20

Question
If the FDA approves a drug, it must be safe
Answer
  • True
  • False

Question 21

Question
If a drug is effective, it works for every one.
Answer
  • True
  • False

Question 22

Question
If a famous doctor recommends this drug, it must be good
Answer
  • True
  • False

Question 23

Question
product claims ads definition is
Answer
  • These name a drug and the condition it treats, and talk about both its benefits and risks
  • They give the drug's name, but not the drug's uses.
  • These describe a disease or condition, but don't recommend or suggest specific drugs.

Question 24

Question
Reminder ads definition is
Answer
  • These name a drug and the condition it treats, and talk about both its benefits and risks
  • They give the drug's name, but not the drug's uses.
  • These describe a disease or condition, but don't recommend or suggest specific drugs.

Question 25

Question
Help-seeking ads definition is
Answer
  • These name a drug and the condition it treats, and talk about both its benefits and risks
  • They give the drug's name, but not the drug's uses.
  • These describe a disease or condition, but don't recommend or suggest specific drugs.

Question 26

Question
DTCA practices have multiple impacts
Answer
  • Health impact
  • Economic impact
  • Image impact
  • Social life impact
  • Law impact

Question 27

Question
DCTA raises concerns by
Answer
  • Increasing OTC drugs' prices
  • Increasing prescription costs
  • Misleading statements lead to irractional use and undue risks
  • Often breaches regulation
  • Strains on physicians-patient relation
  • No evidence of health benefits
  • Decreasing prescription costs

Question 28

Question
DTC advertising is the primary driver of growth in prescription drug spending
Answer
  • True
  • False

Question 29

Question
___________ should fairly represent the study design, objective, methods, and result.
Answer
  • Abstract
  • Introdution
  • Conclusion
  • Method

Question 30

Question
Literature review should be accurate and balanced in ______
Answer
  • Introduction
  • Method
  • Conclusion
  • Evaluation

Question 31

Question
In Method, the design of method should
Answer
  • Show safety
  • Address study objective
  • Allow for support or rejection of null hypothesis
  • Use appropriate analysis (intent to treat or per-protocol)
  • Not address study objective
  • only use per-protocol approach
Show full summary Hide full summary

Similar

PHARMACOLOGY BLOCK 1- basic intro
wallacejr@hotmail.co
PUBLIC HEALTH
Zinab Keshk
Exam 1 Medications
tera_alise
Introduction to pharmacology
Ifeoma Ezepue
Drug receptor interactions
Ifeoma Ezepue
Pharmacology II-III
Gwen Paparone
Pharmacology Chap 10 & 11
Robin Gatson
Monoamine pharmacology -Antidepressant drugs - Dr. Emma Robinson
Anna mph
pharmacology chapter 8 and 20
Alannah Mendoza
module 4 chapter 19
Alannah Mendoza